Suanfarma, at the Core of a Better Life.

Contact Supplier

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

8 API Suppliers, 6 USDMF, 2 CEP/COS, 1 JDMF, 5 NDC API, 4 Listed Suppliers, $ API Reference Price

8 API Suppliers
6 USDMF
2 CEP/COS
1 JDMF
5 NDC API
4 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

FINISHED DOSAGE FORMULATIONS

36 FDF Dossiers, 12 FDA Orange Book, 13 Europe, 5 Canada, 4 Australia, 1 South Africa, 1 Listed Dossiers

36 FDF Dossiers
12 FDA Orange Book
13 Europe
5 Canada
4 Australia
1 South Africa
1 Listed Dossiers

DIGITAL CONTENT

5 NEWS #PharmaBuzz

media
5 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 5 Finished Drug Prices

globalSalesInformation
2 US Medicaid Prescriptions
5 Finished Drug Prices

MARKET PLACE

15 APIs, 3 FDF Dossiers

marketPlace
15 APIs
3 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 EDQM , 1 USP , 1 JP , 1 Others

otherSolutions
1 EDQM
1 USP
1 JP
1 Others

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

133,154

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 138-14-7, Desferal, Desferrioxamine b mesylate, Deferoxamine mesilate, Desferrioxamine mesylate, Deferoxamine methanesulfonate

Molecular Formula

C₂₆H₅₂N₆O₁₁S

Molecular Weight

656.8 g/mol

InChI Key

IDDIJAWJANBQLJ-UHFFFAOYSA-N

FDA UNII

V9TKO7EO6K

Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.

1 2D Structure

Deferoxamine Mesylate

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide;methanesulfonic acid

2.1.2 InChI

InChI=1S/C25H48N6O8.CH4O3S/c1-21(32)29(37)18-9-3-6-16-27-22(33)12-14-25(36)31(39)20-10-4-7-17-28-23(34)11-13-24(35)30(38)19-8-2-5-15-26;1-5(2,3)4/h37-39H,2-20,26H2,1H3,(H,27,33)(H,28,34);1H3,(H,2,3,4)

2.1.3 InChI Key

IDDIJAWJANBQLJ-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O.CS(=O)(=O)O

2.2 Other Identifiers

2.2.1 UNII

V9TKO7EO6K

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Deferoxamine

2. Deferoxamine B

3. Deferoxamine Mesilate

4. Deferoxamine Methanesulfonate

5. Deferoximine

6. Deferrioxamine B

7. Desferal

8. Desferioximine

9. Desferrioxamine

10. Desferrioxamine B

11. Desferrioxamine B Mesylate

12. Desferroxamine

13. Mesilate, Deferoxamine

14. Mesylate, Deferoxamine

15. Mesylate, Desferrioxamine B

16. Methanesulfonate, Deferoxamine

2.3.2 Depositor-Supplied Synonyms

1. 138-14-7

2. Desferal

3. Desferrioxamine B Mesylate

4. Deferoxamine Mesilate

5. Desferrioxamine Mesylate

6. Deferoxamine Methanesulfonate

7. Deferoxamine B Mesylate

8. Deferoxamine (mesylate)

9. Desferal Mesylate

10. Desferrioxamine Mesilate

11. V9tko7eo6k

12. Nsc-756718

13. Mls000028713

14. Desferrioxamine B Mesylate;dfom

15. Ba-33112

16. N-(5-(3-((5-aminopentyl)hydroxycarbamoyl)propionamido)pentyl)-3-((5-(n-hydroxyacetamido)pentyl)carbamoyl)propionohydroxamic Acid Monomethanesulfonate (salt)

17. Ncgc00017021-01

18. Cas-138-14-7

19. Deferoxaminemesylate

20. Desferal (tn)

21. Deferoxamine-d8 Mesylate

22. Deferoxamine Mesylate Salt

23. Dsstox_cid_17649

24. Dsstox_rid_79351

25. Dsstox_gsid_37649

26. N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-n'-(5-aminopentyl)-n'-hydroxybutanediamide;methanesulfonic Acid

27. Desferal Methanesulfonate

28. Chebi:31460

29. Deferoxamine Mesylate [usan]

30. Nsc644468

31. Desferioxamine Mesylate

32. Sr-01000695424

33. Smr000058548

34. Einecs 205-314-3

35. Unii-v9tko7eo6k

36. Ba 33122

37. 138d147

38. Ccris 8311

39. Deferoxamine Mesylate [usan:usp]

40. Deferoxamini Mesilas

41. Prestwick_988

42. Mfcd00058605

43. Chembl1234

44. Deferoxamine Mesylate (usp)

45. Schembl119982

46. Spectrum1500224

47. Deferoxamine Mesilate (jp17)

48. Dtxsid6037649

49. Hms500e04

50. Hms1570a12

51. Hms1920c16

52. Hms2091k08

53. Hms2097a12

54. Hms2234h23

55. Hms3714a12

56. Pharmakon1600-01500224

57. Deferoxamine Mesilate [jan]

58. Bcp31290

59. Ex-a4085

60. Hy-b0988

61. Tox21_110741

62. Ccg-39770

63. Deferoxamine Mesylate [vandf]

64. Nsc756718

65. S5742

66. Akos026750165

67. Deferoxamine Mesilate [who-dd]

68. Deferoxamine Mesilate [who-ip]

69. Deferoxamine Mesylate [usp-rs]

70. Tox21_110741_1

71. Cs-4479

72. Nsc 756718

73. Nsc-644468

74. Desferrioxamine Mesilate [mart.]

75. Desferrioxamine Mesylate [who-ip]

76. Ncgc00017021-02

77. Ncgc00017021-03

78. Ncgc00094640-01

79. Ncgc00094640-02

80. Ncgc00178802-06

81. Ac-36517

82. Butanediamide, N'-(5-((4-((5-(acetylhydroxyamino)pentyl)amino)-1,4-dioxobutyl)hydroxyamino)pentyl)-n-(5-aminopentyl)-n-hydroxy-, Monomethanesulfonate

83. Deferoxamine Mesylate - Cas 138-14-7

84. Deferoxamine Methanesulfonate [mi]

85. Propionohydroxamic Acid, N-(5-(3-((5-aminopentyl)hydroxycarbamoyl)propionamido)pentyl)-3-((5-(n-hydroxyacetamido)pentyl)carbamoyl)-, Monomethanesulfonate (salt)

86. Deferoxamine Mesylate [orange Book]

87. Db-042415

88. Deferoxamine Mesilate [ep Monograph]

89. Deferoxamini Mesilas [who-ip Latin]

90. Deferoxamine Mesylate [usp Monograph]

91. Ft-0603121

92. D01186

93. A807339

94. Sr-01000695424-2

95. Sr-01000695424-3

96. Sr-01000695424-4

97. Deferoxamine Mesylate Salt, Powder, >=92.5% (tlc)

98. Q27114315

99. Desferrioxamine B Mesylate; Dfom;desferrioxamine Mesylate

100. Deferoxamine Mesylate Salt, European Pharmacopoeia (ep) Reference Standard

101. Deferoxamine Mesylate, United States Pharmacopeia (usp) Reference Standard

102. Deferoxamine For System Suitability, European Pharmacopoeia (ep) Reference Standard

103. Butanediamide, N'(-(((((acetylhydroxyamino)pentyl)mino)1,4-dioxobutyl)ydroxyamino)entyl)n-(5-aminopentyl)-n-hydroxy-, Monomethanesulfonate

104. Butanediamide, N'(-(((((acetylhydroxyamino)pentyl)mino)1,4-dioxobutyl)ydroxyamino)entyl)n-(5-aminopentyl)-n-hydroxy-, Monomethanesulphonate

105. N'-(5-azanylpentyl)-n-[5-[[4-[5-[ethanoyl(oxidanyl)amino]pentylamino]-4-oxidanylidene-butanoyl]-oxidanyl-amino]pentyl]-n'-oxidanyl-butanediamide; Methanesulfonic Acid

106. N'-{5-[acetyl(hydroxy)amino]pentyl}-n-[5-({4-[(5-aminopentyl)(hydroxy)amino]-4-oxobutanoyl}amino)pentyl]-n-hydroxysuccinamide Methanesulfonate (salt)

107. N-(5-(3-((5-aminopentyl)hydroxycarbamoyl)propionamido)pentyl)-3-((5-(n-hydroxyacetamido)pentyl)carbamoyl)propionohydroxamic Acid Monomethanesulphonate (salt)

108. N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-1,4-dioxobutyl]-hydroxyamino]pentyl]-n'-(5-aminopentyl)-n'-hydroxybutanediamide; Methanesulfonic Acid

109. N1-(5-(4-((5-aminopentyl)amino)-4-oxobutanamido)pentyl)-n1-hydroxy-n4-(5-(n-hydroxyacetamido)pentyl)succinamide Methanesulfonate

110. N1-(5-aminopentyl)-n1-hydroxy-n4-(5-(n-hydroxy-4-(5-(n-hydroxyacetamido)pentylamino)-4-oxobutanamido)pentyl)succinamide Methanesulfonate

111. N4-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino-1,4-dioxobutyl]hydroxyamino]pentyl]-n1-(5-aminopentyl)-n1-hydroxybutanediamide Methanesulfonate

2.4 Create Date

2005-03-26

3 Chemical and Physical Properties

Molecular Formula	C₂₆H₅₂N₆O₁₁S
Molecular Weight	656.8 g/mol
Hydrogen Bond Donor Count	7
Hydrogen Bond Acceptor Count	12
Rotatable Bond Count	23
Exact Mass	656.34147767 g/mol
Monoisotopic Mass	656.34147767 g/mol
Topological Polar Surface Area	269 Å²
Heavy Atom Count	44
Formal Charge	0
Complexity	832
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2

4 Drug and Medication Information

4.1 Drug Information

1 of 4
Drug Name	Deferoxamine mesylate
Drug Label	Deferoxamine mesylate for injection, USP, is an iron-chelating agent, available in vials for intramuscular, subcutaneous, and intravenous administration. Deferoxamine mesylate is supplied as vials containing 500 mg and 2 g of deferoxamine mesylate US...
Active Ingredient	Deferoxamine mesylate
Dosage Form	Injectable
Route	Injection
Strength	500mg/vial; 2gm/vial
Market Status	Prescription
Company	Fresenius Kabi Usa; Hospira; Eurohlth Intl

2 of 4
Drug Name	Desferal
PubMed Health	Deferoxamine (Injection)
Drug Classes	Heavy Metal Chelator
Drug Label	Desferal, deferoxamine mesylate USP, is an iron-chelating agent, available in vials for intramuscular, subcutaneous, and intravenous administration. Desferal is supplied as vials containing 500 mg and 2 g of deferoxamine mesylate USP in sterile, lyop...
Active Ingredient	Deferoxamine mesylate
Dosage Form	Injectable
Route	Injection
Strength	500mg/vial; 2gm/vial
Market Status	Prescription
Company	Novartis

3 of 4
Drug Name	Deferoxamine mesylate
Drug Label	Deferoxamine mesylate for injection, USP, is an iron-chelating agent, available in vials for intramuscular, subcutaneous, and intravenous administration. Deferoxamine mesylate is supplied as vials containing 500 mg and 2 g of deferoxamine mesylate US...
Active Ingredient	Deferoxamine mesylate
Dosage Form	Injectable
Route	Injection
Strength	500mg/vial; 2gm/vial
Market Status	Prescription
Company	Fresenius Kabi Usa; Hospira; Eurohlth Intl

4 of 4
Drug Name	Desferal
PubMed Health	Deferoxamine (Injection)
Drug Classes	Heavy Metal Chelator
Drug Label	Desferal, deferoxamine mesylate USP, is an iron-chelating agent, available in vials for intramuscular, subcutaneous, and intravenous administration. Desferal is supplied as vials containing 500 mg and 2 g of deferoxamine mesylate USP in sterile, lyop...
Active Ingredient	Deferoxamine mesylate
Dosage Form	Injectable
Route	Injection
Strength	500mg/vial; 2gm/vial
Market Status	Prescription
Company	Novartis

5 Pharmacology and Biochemistry

5.1 MeSH Pharmacological Classification

Siderophores

Low-molecular-weight compounds produced by microorganisms that aid in the transport and sequestration of ferric iron. (The Encyclopedia of Molecular Biology, 1994) (See all compounds classified as Siderophores.)

5.2 FDA Pharmacological Classification

5.2.1 Pharmacological Classes

Iron Chelator [EPC]; Iron Chelating Activity [MoA]

API SUPPLIERS

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

01

Teva Pharmaceutical Industries Ltd

Israel

CPhI WW Frankfurt

Booth #6.1A32

TAPI offers customized CDMO Solutions for API development and manufacturing services.

Contact Supplier

Israel

Virtual Booth

Digital Content

DEFEROXAMINE MESYLATE

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 12241

Submission : 1996-12-02

Status : Active

Type : II

Corporate PDF

02

Excella Gmbh And Co Kg

Luxembourg

Duphat

Not Confirmed

03

Excella Gmbh And Co Kg

Luxembourg

Duphat

Not Confirmed

04

Mythen Spa

Italy

Duphat

Not Confirmed

05

Mythen Spa

Italy

Duphat

Not Confirmed

06

Pharmacia And Upjohn

U.S.A

Duphat

Not Confirmed

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

CEP/COS

01

TEVA PHARMACEUTICAL INDUSTRIES LTD ...

Israel

CPhI WW Frankfurt

Booth #6.1A32

TAPI offers customized CDMO Solutions for API development and manufacturing services.

Contact Supplier

Israel

Virtual Booth

Digital Content

Deferoxamine Mesilate, Produced By Fermentation

Certificate Number : R1-CEP 2000-160 - Rev 04

Status : Valid

Issue Date : 2022-06-17

Type : Chemical

Substance Number : 896

Corporate PDF

02

EXCELLA GMBH & CO. KG Feucht DE

Luxembourg

Duphat

Not Confirmed

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

JDMF

01

Excella GmbH & Co. K.G.

Luxembourg

Duphat

Teva Pharmaceutical Works Private L...

Israel

Duphat

Not Confirmed

05

TAPI Hungary Industries Kft.

Country

Duphat

Not Confirmed

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

01

TAPI Technology & API Services

Israel

CPhI WW Frankfurt

Booth #6.1A32

TAPI offers customized CDMO Solutions for API development and manufacturing services.

Contact Supplier

Israel

Virtual Booth

Digital Content

Deferoxamine Mesylate

About the Company : Founded in 1935, TAPI Technology & API Services has a long-standing tradition of advancing health through innovation and dedication. Today, we proudly build upon this legacy, drivi...

Founded in 1935, TAPI Technology & API Services has a long-standing tradition of advancing health through innovation and dedication. Today, we proudly build upon this legacy, driving progress in the pharmaceutical industry. Leveraging our extensive experience and world-class expertise, we deliver one of the most comprehensive API portfolios in the industry. Additionally, we provide tailored CDMO services, harnessing our proficiency in diverse technologies to meet our partners' unique needs, ensuring flexibility and excellence in every project.

Corporate PDF

02

Fareva

Luxembourg

Duphat

Not Confirmed

03

Olon S.p.A

Italy

Duphat

Not Confirmed

04

Teva Pharmaceutical Industries

Israel

Duphat

Not Confirmed

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

[{"dataSource":"API Export","activeIngredients":"DEFEROXAMINE MESYLATE","year":"2021","qtr":"Q1","strtotime":1610389800,"product":"DEFEROXAMINE MESYLATE STERILE(USP(B.NO.","address":"ROOM NO 1 UNIT NO 501 5TH FLOOR,AG GARWAL CORPORATE HEIGHTS NSP","city":"NEW DELHI,DELHI","supplier":"VEDIC INDIA","supplierCountry":"INDIA","foreign_port":"TEHRAN","customer":"TO THE ORDER OF","customerCountry":"IRAN","quantity":"250.00","actualQuantity":"250","unit":"KGS","unitRateFc":"203915","totalValueFC":"697035.9","currency":"INR","unitRateINR":203916,"date":"12-Jan-2021","totalValueINR":"50979000","totalValueInUsd":"697035.9","indian_port":"DELHI AIR","hs_no":"29280090","bill_no":"7847171","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"IRAN","selfForZScoreResived":"Sterile","supplierPort":"DELHI AIR","supplierAddress":"ROOM NO 1 UNIT NO 501 5TH FLOOR,AG GARWAL CORPORATE HEIGHTS NSP, NEW DELHI,DELHI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1703701800,"product":"DEFEROXAMINE MESYLATE(STERILE)USP(B.NO.:SI\/DFM\/00081223,SI\/DFM\/00091223 M.DECEMBER-2023 E.NOVEMBER-2026)","address":"1705, 4TH FLOOR, ONKAR BHAWAN","city":"DELHI","supplier":"STERILE INDIA PVT. LTD","supplierCountry":"INDIA","foreign_port":"HONG KONG","customer":"TO THE ORDER OF","customerCountry":"HONG KONG","quantity":"200.00","actualQuantity":"200","unit":"KGS","unitRateFc":"2465.9","totalValueFC":"531347","currency":"EUR","unitRateINR":221155,"date":"28-Dec-2023","totalValueINR":"44231000","totalValueInUsd":"531347","indian_port":"Delhi Air","hs_no":"29280090","bill_no":"6349230","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"HONG KONG","selfForZScoreResived":"Sterile","supplierPort":"Delhi Air","supplierAddress":"1705, 4TH FLOOR, ONKAR BHAWAN, DELHI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1727375400,"product":"PHARMACEUTICALS RAW MATERIALS (DEFEROXAMINE MESYLATE (STERILE)USP(B.NO.SI\/DFM\/00010824 M:8\/24, E: 7\/27))","address":"1705, 4TH FLOOR, ONKAR BHAWAN","city":"DELHI","supplier":"STERILE INDIA PVT. LTD","supplierCountry":"INDIA","foreign_port":"HONG KONG","customer":"TO THE ORDER OF:","customerCountry":"HONG KONG","quantity":"113.00","actualQuantity":"113","unit":"KGS","unitRateFc":"2565","totalValueFC":"315766.3","currency":"EUR","unitRateINR":234173.49902654867,"date":"27-Sep-2024","totalValueINR":"26461605.39","totalValueInUsd":"315766.3","indian_port":"Delhi Air","hs_no":"29280090","bill_no":"4383956","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"HONG KONG","selfForZScoreResived":"Sterile","supplierPort":"Delhi Air","supplierAddress":"1705, 4TH FLOOR, ONKAR BHAWAN, DELHI","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1640111400,"product":"DEFEROXAMINE MESYLATE USP HN","address":"501 5TH FLOOR AGGARWAL CORPORATE HEIGHTS PLOT NO A-7 N.S.P, PITAMPUR","city":"NEW DELHI","supplier":"FAREVA","supplierCountry":"GERMANY","foreign_port":"N\/A","customer":"STERILE INDIA PVT. LTD","customerCountry":"INDIA","quantity":"290.00","actualQuantity":"290","unit":"KGS","unitRateFc":"1550","totalValueFC":"522645.6","currency":"EUR","unitRateINR":"135935","date":"22-Dec-2021","totalValueINR":"39421150","totalValueInUsd":"522645.6","indian_port":"DELHI AIR","hs_no":"29280090","bill_no":"6786686","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"N\/A","supplierAddress":"","customerAddress":"501 5TH FLOOR AGGARWAL CORPORATE HEIGHTS PLOT NO A-7 N.S.P, PITAMPUR"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1651429800,"product":"DEFEROXAMINE MESYLATE USP HN","address":"501 5TH FLOOR AGGARWAL CORPORATE HEIGHTS PLOT NO A-7 N.S.P, PITAMPUR","city":"NEW DELHI","supplier":"FAREVA","supplierCountry":"GERMANY","foreign_port":"NA","customer":"STERILE INDIA PVT. LTD","customerCountry":"INDIA","quantity":"544.00","actualQuantity":"544","unit":"KGS","unitRateFc":"1550","totalValueFC":"918090.4","currency":"EUR","unitRateINR":"130432.5","date":"02-May-2022","totalValueINR":"70955280","totalValueInUsd":"918090.4","indian_port":"DELHI AIR","hs_no":"29280090","bill_no":"8512263","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"501 5TH FLOOR AGGARWAL CORPORATE HEIGHTS PLOT NO A-7 N.S.P, PITAMPUR"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1662921000,"product":"DEFEROXAMINE MESYLATE USP","address":"Part of Plot No.11 & 87, Sy No.119 Phase - IV, Extension in IP, Pasham","city":"HYDERABAD","supplier":"FAREVA","supplierCountry":"GERMANY","foreign_port":"NA","customer":"GLAND PHARMA LIMITED","customerCountry":"INDIA","quantity":"57.50","actualQuantity":"57.5","unit":"KGS","unitRateFc":"2750","totalValueFC":"160394.7","currency":"EUR","unitRateINR":"223551.3","date":"12-Sep-2022","totalValueINR":"12854196.88","totalValueInUsd":"160394.7","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"2404024","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"Part of Plot No.11 & 87, Sy No.119 Phase - IV, Extension in IP, Pasham"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1669746600,"product":"DEFEROXAMINE MESYLATE USP","address":"501 5TH FLOOR AGGARWAL CORPORATE HEIGHTS PLOT NO A-7 N.S.P, PITAMPUR","city":"NEW DELHI","supplier":"EXCELLA GMBH","supplierCountry":"GERMANY","foreign_port":"NA","customer":"STERILE INDIA PVT. LTD","customerCountry":"INDIA","quantity":"350.00","actualQuantity":"350","unit":"KGS","unitRateFc":"1550","totalValueFC":"573325.5","currency":"EUR","unitRateINR":"133687.5","date":"30-Nov-2022","totalValueINR":"46790625","totalValueInUsd":"573325.5","indian_port":"DELHI AIR","hs_no":"29280090","bill_no":"3531742","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"501 5TH FLOOR AGGARWAL CORPORATE HEIGHTS PLOT NO A-7 N.S.P, PITAMPUR"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1676053800,"product":"DEFEROXAMINE MESYLATE","address":"M-134, 2ND FLOOR CONNAUGHT CIRCUS","city":"NEW DELHI","supplier":"FLAVINE","supplierCountry":"GERMANY","foreign_port":"NA","customer":"RAJASTHAN ANTIBIOTICS","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"5500","totalValueFC":"5510.7","currency":"USD","unitRateINR":"455125","date":"11-Feb-2023","totalValueINR":"455125","totalValueInUsd":"5510.7","indian_port":"DELHI AIR","hs_no":"29280090","bill_no":"4600717","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"M-134, 2ND FLOOR CONNAUGHT CIRCUS"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1680719400,"product":"DEFEROXAMINE MESYLATE USP","address":"501 5TH FLOOR AGGARWAL CORPORATE HEIGHTS PLOT NO A-7 N.S.P, PITAMPUR","city":"NEW DELHI","supplier":"EXCELLA GMBH &CO.KG","supplierCountry":"GERMANY","foreign_port":"NA","customer":"STERILE INDIA PVT. LTD","customerCountry":"INDIA","quantity":"400.00","actualQuantity":"400","unit":"KGS","unitRateFc":"1600","totalValueFC":"697759.2","currency":"EUR","unitRateINR":"142960","date":"06-Apr-2023","totalValueINR":"57184000","totalValueInUsd":"697759.2","indian_port":"DELHI AIR","hs_no":"29280090","bill_no":"5391137","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"501 5TH FLOOR AGGARWAL CORPORATE HEIGHTS PLOT NO A-7 N.S.P, PITAMPUR"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1717439400,"product":"DEFEROXAMINE MESYLATE USP","address":"6-3-865\/1\/2, FLAT NO.201,","city":"HYDERABAD, ANDHRA PRADESH","supplier":"FAREVA","supplierCountry":"GERMANY","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"GLAND PHARMA LTD","customerCountry":"INDIA","quantity":"21.00","actualQuantity":"21","unit":"KGS","unitRateFc":"2200","totalValueFC":"51265","currency":"EUR","unitRateINR":"203789.1","date":"04-Jun-2024","totalValueINR":"4279570.31","totalValueInUsd":"51265","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"3819819","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"FRANKFURT\/MAIN INT\\'L","supplierAddress":"NUMBERGER STR 12, D-90537 FEUCHT, GERMANYSDNF Germany","customerAddress":"6-3-865\/1\/2, FLAT NO.201,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1723401000,"product":"DEFEROXAMINE MESYLATE USP","address":"1705, 4TH FLOOR, ONKAR BHAWAN","city":"DELHI","supplier":"EXCELLA GMBA & CO.KG","supplierCountry":"GERMANY","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"STERILE INDIA PVT. LTD","customerCountry":"INDIA","quantity":"84.00","actualQuantity":"84","unit":"KGS","unitRateFc":"2145","totalValueFC":"198162.8","currency":"EUR","unitRateINR":"197876.3","date":"12-Aug-2024","totalValueINR":"16621605","totalValueInUsd":"198162.8","indian_port":"Delhi Air","hs_no":"29280090","bill_no":"5016777","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"FRANKFURT\/MAIN INT\\'L","supplierAddress":"NURNBERGER STR.12D-90537 FEUCHTGERMANY SDNF","customerAddress":"1705, 4TH FLOOR, ONKAR BHAWAN"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1724610600,"product":"DEFEROXAMINE MESYLATE USP","address":"6-3-865\/1\/2, FLAT NO.201,","city":"HYDERABAD, ANDHRA PRADESH","supplier":"FAREVA","supplierCountry":"GERMANY","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"GLAND PHARMA LTD","customerCountry":"INDIA","quantity":"11.80","actualQuantity":"11.8","unit":"KGS","unitRateFc":"3100","totalValueFC":"40978.6","currency":"EUR","unitRateINR":"291290.1","date":"26-Aug-2024","totalValueINR":"3437223.28","totalValueInUsd":"40978.6","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"5253262","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"FRANKFURT\/MAIN INT\\'L","supplierAddress":"NUMBERGER STR 12, D-90537 FEUCHT, GERMANYSDNF Germany","customerAddress":"6-3-865\/1\/2, FLAT NO.201,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1724610600,"product":"DEFEROXAMINE MESYLATE USP","address":"6-3-865\/1\/2, FLAT NO.201,","city":"HYDERABAD, ANDHRA PRADESH","supplier":"FAREVA","supplierCountry":"GERMANY","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"GLAND PHARMA LTD","customerCountry":"INDIA","quantity":"53.00","actualQuantity":"53","unit":"KGS","unitRateFc":"3100","totalValueFC":"183988.6","currency":"EUR","unitRateINR":"291182.9","date":"26-Aug-2024","totalValueINR":"15432694","totalValueInUsd":"183988.6","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"5253262","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"FRANKFURT\/MAIN INT\\'L","supplierAddress":"NUMBERGER STR 12, D-90537 FEUCHT, GERMANYSDNF Germany","customerAddress":"6-3-865\/1\/2, FLAT NO.201,"}]

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country	Total Quantity (KGS)	Average Price (USD/KGS)	Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

01 Novartis Pharmaceuticals Corporation

Switzerland

Duphat

Not Confirmed

02 Theris Medical

U.S.A

Duphat

Not Confirmed

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

01

DR REDDYS

India

CPhI WW Frankfurt

Booth #9.1B48

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

India

Virtual Booth

Digital Content

RLD : No

TE Code :

DEFEROXAMINE MESYLATE

Brand Name : DEFEROXAMINE MESYLATE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 500MG/VIAL

Approval Date : 2006-03-31

Application Number : 76806

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Product Web Link

02

DR REDDYS

India

CPhI WW Frankfurt

Booth #9.1B48

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

India

Virtual Booth

Digital Content

RLD : No

TE Code :

DEFEROXAMINE MESYLATE

Brand Name : DEFEROXAMINE MESYLATE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 2GM/VIAL

Approval Date : 2006-03-31

Application Number : 76806

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Portfolio PDF

Product Web Link

NOVARTIS

Switzerland

Duphat

Not Confirmed

Only 10 entries up to this point, click to access all

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

01

Novartis Pharma Schweiz AG

Switzerland

Duphat

Not Confirmed

02

Olon Spa

Italy

Duphat

Not Confirmed

03

Olon Spa

Italy

Duphat

Not Confirmed

04

Orifarm AB

Denmark

Denmark

Country

Duphat

Not Confirmed

Only 10 entries up to this point, click to access all

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Canada

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Australia

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

South Africa

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Dossiers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

Global Sales Information

Do you need Business Intel? Ask us

Country

Duphat

Not Confirmed

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

APIs

Deferoxamine Mesylate (2 kg) API needed in Iraq [ENA18989]

A company that focuses on producing very high quality intravenous solutions, oral solutions in PP bottles, eye drops and other medicament injectable solutions is looking for suppliers of Deferoxamine Mesylate (2 kg) API for development purposes. The suppliers must support this enquiry with CoA.

03 Feb 2024

USP & Injectable Grade Deferoxamine Mesylate API needed in Jordan [ENA16522]

A company that deals in the development, production, and distribution of specialty medicines & generic products is looking for suppliers of USP & Injectable Grade Deferoxamine Mesylate (1 MT) API for commercial purposes. The suppliers must support this enquiry with CEP or USDMF.

02 Mar 2023

Various APIs needed in Malaysia [ENA15839]

A pharmaceutical company that focuses on research, development & manufacturing of complex, niche, technology-intensive and highly technical generics for all therapeutic areas is looking for suppliers of Various APIs for development purposes. The suppliers must support this enquiry with CoA. 1. Paclitaxel API 2. Azacitidine API 3. Bendamustine HCl API 4. Bortezomib API 5. Deferoxamine Mesylate API 6. Pemetrexed Disodium Heptahydrate API 7. Docetaxel Trihydrate API 8. Fulvestrant API

16 Dec 2022

Deferoxamine Mesylate (10 g) API needed in the United States [ENA13478]

A biopharmaceutical company that specializes in discovering, development and commercialization of innovative medicines is looking for suppliers of Deferoxamine Mesylate (10 g) API for development purpose. The suppliers must support this enquiry with USDMF & GMP.

29 Apr 2022

Deferoxamine Base (0.5 kg) API needed in India [ENA11419]

A company that deals in the manufacturing & development of various active pharmaceutical ingredients is looking for suppliers Deferoxamine Base (0.5 kg) API for development purpose. The suppliers must support this enquiry with CoA.

16 Sep 2021

Injectable Grade Deferoxamine Mesylate (550 kg) API needed in Vietnam [ENA09990]

A pharmaceutical company that manufactures OTC medicines is looking for suppliers of Injectable Grade Deferoxamine Mesylate (550 kg) API for commercial purposes.

18 Mar 2021

Various APIs needed in Iran [ENA09940]

A company that deals in encapsulation of micro and nanomaterials active in the pharmaceutical, supplement, detergent, cosmetic, food and feed industries is looking for suppliers of Various APIs for commercial purposes. The suppliers must support this enquiry with GMP and CoA. 1. Sterile Vancomycin HCl (500 kg) API 2. Sterile Teicoplanin (100 kg) API 3. Sterile Daptomycin (50 kg) API 4. Sterile Deferoxamine Mesylate (500 kg) API 5. Acarbose (1 MT) API 6. Orlistat (1 MT) API

13 Mar 2021

Deferoxamine Mesylate (MOQ) API needed in India [ENA09909]

A company that deals in manufacturing pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs and disposable syringes & needles is looking for suppliers of Deferoxamine Mesylate (MOQ) API for development purposes. The suppliers must support this enquiry with CoA.

09 Mar 2021

Deferoxamine Mesylate (1 kg) API needed in India [ENA09696]

A company that deals in the manufacturing of various active pharmaceutical ingredients is looking for suppliers of Deferoxamine Mesylate (1 kg) API for R&D purposes.

09 Feb 2021

Deferoxamine Mesylate (10 g - 100 g) API needed in India [ENA09086]

Ria International, a distributor and importer of raw materials for the nutraceutical and pharmaceutical industries is looking for suppliers of Deferoxamine Mesylate (10 g - 100 g) API. The supplier must support this enquiry with CoA. Interested suppliers can contact them via their email: prasannas@riausa.net.

19 Nov 2020

Only 10 entries up to this point, click to access all

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF DOSSIERS

Various Finished Dosage Formulations needed in Jordan [ENA11630]

A company that deals in the distribution of various pharmaceutical products is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The suppliers must support this enquiry with EU dossiers for each. 1. Natalizumab (20 mg/ ml in 15 ml) Concentrate for IV Solution. The required quantity is 5,700 units. 2. Deferoxamine mesylate (500 mg) Vials. The required quantity is 1,650,000 units. 3. Tocilizumab (200 mg/ 10 ml) Vials. The required quantity is 1,300 units. 4. Rituximab (500 mg) Vials. The required quantity is 36,000 units.

13 Oct 2021

Deferoxamine Mesylate (0.5 g & 1 g) Injections needed in Pakistan [ENA08235]

Alphaevolution Enterprises, an export/import oriented company based in Pakistan is looking for suppliers of Deferoxamine Mesylate (0.5 g & 1 g) Injections. The required quantity is 200,000 units for each. The suppliers must support this enquiry with dossiers. Interested suppliers can contact them via their email: alphaevolution@outlook.com.

14 Aug 2020

Looking for CTD dossier of Azithromycin and Deferoxamine injections [ENA05248]

A joint stock company owned by a group of Lebanese developing sterile injectables is looking for Azithromycin and Deferoxamine injections (CTD Dossier). The required dosage strength is 500 mg for each injection.

24 Sep 2019

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

EDQM

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USP

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Others

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Deferoxamine Mesylate Manufacturers

A Deferoxamine Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Deferoxamine Mesylate, including repackagers and relabelers. The FDA regulates Deferoxamine Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Deferoxamine Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Deferoxamine Mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Deferoxamine Mesylate Suppliers

A Deferoxamine Mesylate supplier is an individual or a company that provides Deferoxamine Mesylate active pharmaceutical ingredient (API) or Deferoxamine Mesylate finished formulations upon request. The Deferoxamine Mesylate suppliers may include Deferoxamine Mesylate API manufacturers, exporters, distributors and traders.

click here to find a list of Deferoxamine Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Deferoxamine Mesylate USDMF

A Deferoxamine Mesylate DMF (Drug Master File) is a document detailing the whole manufacturing process of Deferoxamine Mesylate active pharmaceutical ingredient (API) in detail. Different forms of Deferoxamine Mesylate DMFs exist exist since differing nations have different regulations, such as Deferoxamine Mesylate USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Deferoxamine Mesylate DMF submitted to regulatory agencies in the US is known as a USDMF. Deferoxamine Mesylate USDMF includes data on Deferoxamine Mesylate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Deferoxamine Mesylate USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Deferoxamine Mesylate suppliers with USDMF on PharmaCompass.

Deferoxamine Mesylate JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Deferoxamine Mesylate Drug Master File in Japan (Deferoxamine Mesylate JDMF) empowers Deferoxamine Mesylate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Deferoxamine Mesylate JDMF during the approval evaluation for pharmaceutical products. At the time of Deferoxamine Mesylate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Deferoxamine Mesylate suppliers with JDMF on PharmaCompass.

Deferoxamine Mesylate CEP

A Deferoxamine Mesylate CEP of the European Pharmacopoeia monograph is often referred to as a Deferoxamine Mesylate Certificate of Suitability (COS). The purpose of a Deferoxamine Mesylate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Deferoxamine Mesylate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Deferoxamine Mesylate to their clients by showing that a Deferoxamine Mesylate CEP has been issued for it. The manufacturer submits a Deferoxamine Mesylate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Deferoxamine Mesylate CEP holder for the record. Additionally, the data presented in the Deferoxamine Mesylate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Deferoxamine Mesylate DMF.

A Deferoxamine Mesylate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Deferoxamine Mesylate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Deferoxamine Mesylate suppliers with CEP (COS) on PharmaCompass.

Deferoxamine Mesylate NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Deferoxamine Mesylate as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Deferoxamine Mesylate API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Deferoxamine Mesylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Deferoxamine Mesylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Deferoxamine Mesylate NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Deferoxamine Mesylate suppliers with NDC on PharmaCompass.

Deferoxamine Mesylate GMP

Deferoxamine Mesylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Deferoxamine Mesylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Deferoxamine Mesylate GMP manufacturer or Deferoxamine Mesylate GMP API supplier for your needs.

Deferoxamine Mesylate CoA

A Deferoxamine Mesylate CoA (Certificate of Analysis) is a formal document that attests to Deferoxamine Mesylate's compliance with Deferoxamine Mesylate specifications and serves as a tool for batch-level quality control.

Deferoxamine Mesylate CoA mostly includes findings from lab analyses of a specific batch. For each Deferoxamine Mesylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Deferoxamine Mesylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Deferoxamine Mesylate EP), Deferoxamine Mesylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Deferoxamine Mesylate USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.

Find Deferoxamine Mesylate manufacturers, exporters & distributors on PharmaCompass

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

8 API Suppliers

6 USDMF

2 CEP/COS

1 JDMF

5 NDC API

4 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

FINISHED DOSAGE FORMULATIONS

36 FDF Dossiers

12 FDA Orange Book

13 Europe

5 Canada

4 Australia

1 South Africa

1 Listed Dossiers

DIGITAL CONTENT

5 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions

5 Finished Drug Prices

MARKET PLACE

15 APIs

3 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 EDQM

1 USP

1 JP

1 Others

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 2,014

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

01

02

02

03

03

04

04

05

05

06

06

R1-CEP 2000-160 - Rev 04

Valid

Chemical

2022-06-17

896

01

CEP 2009-401 - Rev 05

Valid

Chemical

2024-10-25

896

02

01

01

02

03

04

05

TAPI Hungary Industries Kft.

TAPI Hungary Industries Kft.